John T. Treace Insider Profile
11 Followers
John T. Treace, CEO, Director, Ten Percent Owner at Treace Medical Concepts, holds 12.65M shares in Treace Medical Concepts (Ticker: TMCI). Most recently, John T. Treace Bought 50,000 shares of Treace Medical Concepts on Jun 01, 2026 for an estimated value of $177.50K.
John T. Treace Treace Medical Concepts (TMCI)CEO, Director, Ten Percent Owner
Treace Medical Concepts (TMCI)
CEO, Director, Ten Percent Owner
Ranked #6,259 out of 107,686 Corporate Insiders
Profitable Transactions
15 out of 16 Profitable Transactions
Average Return
+18.70%
Average return per transaction
Time Frame
Compare to
Insider Roles
CEO, Director, Ten Percent Owner
Roles that John T. Treace holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 13, 2024 - May 13, 2025
Return:+54.00%
The most profitable trade made by John T. Treace
John T. Treace's Trading History
List of latest transactions for each holding click on a transaction to see John T. Treace's performance on stock
You May Also Like
John T. Treace insider profile FAQ
What is the percentage of profitable transactions made by John T. Treace?
The percentage of profitable transactions made by John T. Treace is 94%.
What is the average return per transaction made by John T. Treace?
The average return per transaction made by John T. Treace is 18.70%.
What stocks does John T. Treace hold?
John T. Treace holds: TMCI stocks.
What was John T. Treace’s latest transaction?
John T. Treace latest transaction was an Informative Buy of $177.50K.
What was John T. Treace's most profitable transaction?
John T. Treace’s most profitable transaction was an Informative Buy of TMCI stock on May 13, 2024. The return on the trade was 54.00%.
What is John T. Treace's role in Treace Medical Concepts?
John T. Treace's role in Treace Medical Concepts is CEO, Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.